This document was made by the Public Health Agency of Canada in collaboration with the National Advisory Committee on Immunization and the Canadian Immunization Committee to provide guidance regarding the annual influenza vaccine during the COVID-19 pandemic.
This publication discusses the added complexities around the influenza vaccine in light of COVID-19, who should continue to receive the influenza vaccine, and further influenza vaccine safety measures.
This communication from the Prime Minister's office reveals the federal government's efforts to secure a sixth COVID-19 vaccination for Canadians.
This page outlines the details of the vaccine procurement and the agreements made with these companies as well as their partnership with the COVID-19 Vaccine Global Access (COVAX) Facility.
This guidance document was created as a way to address how the COVID-19 pandemic may influence the Fall 2020 influenza vaccination as both the seasonal influenza and COVID-19 burden the healthcare system.
This report outlines the challenges posed by COVID-19 and the Public Health Agency of Canada, the Canadian Immunization Committee, and the National Advisory Committee on Immunization and their recommendations for the Fall 2020 influenza immunization programs.